CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
Byung-Cheol Song, Yoo-Kyung Cho, Hyeyoung Jwa, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong
Clin Mol Hepatol. 2014;20(4):355-360.   Published online 2014 December 24    DOI: https://doi.org/10.3350/cmh.2014.20.4.355

Excel Download

Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
Clinical and Molecular Hepatology. 2014;20(4):355   Crossref logo
Link1 Link2

Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa-2b in HBeAg-positive patients
Journal of Gastroenterology and Hepatology. 2010;25(9):1498-1506   Crossref logo
Link1

Current treatments for patients with HBeAg-positive chronic hepatitis B virus infection: a comparison focusing on HBeAg seroconversion
Liver International. 2010;30(4):512-520   Crossref logo
Link1

Prediction of spontaneous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients during the immune clearance phase
Journal of Medical Virology. 2014;86(11):1838-1844   Crossref logo
Link1 Link2

The importance of HBV genotype in HBeAg-positive chronic hepatitis B patients in whom sustained response is pursued
Journal of Hepatology. 2011;54(2):395-396   Crossref logo
Link1 Link2

49 Association between HBeAg seroconversion and sustained HBV-DNA suppression in patients treated with peginterferon alpha-2a (40KD) (PEGASYS) for HBeAg-positive chronic hepatitis B (CHB)
Journal of Hepatology. 2006;44:S23   Crossref logo
Link1 Link2

HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C
Hepatology. 2002;36(6):1425-1430   Crossref logo
Link1 Link2

HBV pre-core mutant in genotype-D infected children is selected during HBeAg/anti-HBe seroconversion and leads to HBeAg negative chronic hepatitis B in adulthood
Journal of Medical Virology. 2018;90(7):1232-1239   Crossref logo
Link1 Link2

532 Frequency of HBeAg loss and long-term antiviral suppression under nucleos(t)ide treatment in HBeAg positive chronic hepatitis B
Journal of Hepatology. 2005;42:193   Crossref logo
Link1 Link2

406 Interferon therapy improves prognosis in patients with HBeAg positive chronic hepatitis B
Journal of Hepatology. 2005;42:149   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.